Hydroxyethyl starch inhibits endothelium-derived relaxation in porcine coronary arteries

Pharmacology

Volumn 81, Issue 3, 2008, Pages 241-245

  Dagtekin, Oguzhan ^a,b   Krep, Henning ^a   Fischer, Jürgen Hartmut ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Endothelial function; Endothelium derived hyperpolarizing factor; Hydroxyethyl starch; Hydroxyethyl starch solutions

Indexed keywords

BRADYKININ; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HETASTARCH; N(G) NITROARGININE; NITRIC OXIDE; PROSTAGLANDIN F2 ALPHA; VON WILLEBRAND FACTOR;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG EFFECT; ENDOTHELIUM; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SWINE; VASODILATATION;

EID: 41349087280     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000114448     Document Type: Article

References (25)

1. Boulanger CM, Vanhoutte PM: The Endothelium: A Pivotal Role in Health and Cardiovascular Disease. Courbevoie, Servier International, 1994, pp 11-20.
2. Félétou M, Vanhoutte PM: Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 2006;26:1215.
3. Fleming I, Bauersachs J, Busse R: Paracrine function of the coronary vascular endothelium. Mol Cell Biochem 1996;157:137-145.
4. He GW: Effect and mechanism of cardioplegic arrest on the coronary endothelium-smooth muscle interaction. Clin Exp Pharmacol Physiol 1998;25:831.
5. Laxenaire MC, Charpentier C, Feldman L: Réactions anaphylactoïdes aux substituts colloïdeaux du plasma: incidence, facteurs de risque, mécanismes. Enquête prospective multicentrique française. Ann Fr Anesth Réanim 1994;13:301-310.
6. Treib J, Haass A, Pindur G, Wenzel E, Schimrigk K: Blutungskomplikationen durch Hydroxyethylstärke sind vermeidbar. Dt Ärztebl 1997;4:A2326-A2330.
7. Handrigan MT, Burns AR, Donnachie EM, Bowden RA: Hydroxyethyl starch inhibits neutrophil adhesion and transendothelial migration. Shock 2005;24:434-439.
8. Nohé B, Burchard M, Zanke C, Eichner M, Krump-Konvalinkova V, Kirkpatrick CJ, Dieterich HJ: Endothelial accumulation of hydroxyethyl starch and functional consequences on leucocyte-endothelial interactions. Eur Surg Res 2002;34:364-372.
9. Nohé B, Johannes T, Reutershan J, Rothmund A, Haeberle HA, Ploppa A, Schroeder TH, Dieterich HJ: Synthetic colloids attenuate leukocyte- endothelial interactions by inhibition of integrin function. Anesthesiology 2005;103:759-767.
10. Fischer JH, Steinhoff M: Effects of aprotinin on endothelium-dependent relaxation of large coronary arteries. Eur J Cardiothorac Surg 2005;28:801-804.
11. Boon JC, Jesch F, Ring J, Messmer K: Intravascular persistence of hydroxyethyl starch in man. Eur Surg Res 1976;8:497-503.
12. Asskali F, Forster H: The accumulation of different substituted hydroxyethyl starches following repeated infusions in healthy volunteers. Anästhesiol Intensivmed Not-fallmed Schmerzther 1999;34:537-541.
13. Kohler H, Zschiedrich H, Linfante A, Appel F, Pitz H, Clasen R: The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine. Klin Wochenschr 1982;60:293-301.
14. Jesch F, Hübner G, Zumtobel V, Zimmermann M, Messmer K: Hydroxyethyl starch (HAES 450/0.7) in human plasma and liver: course of concentration and histological changes. Infusionsther Klin Ernähr 1979;6:112-117.
15. Treib J, Haass A, Pindur G: Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 1997;78:974-983.
16. Symington BE: Hetastarch and bleeding complications. Ann Intern Med 1986;105:627-628.
17. Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H: Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993;342:248-249.
18. Cittanova ML, Leblanc I, Legendre C, Moquet C, Riou B, Coriat P: Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996;348:1620-1622.
19. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L: Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911-916.
20. Bork K: Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol 2005;152:3-12.
21. Cowan CL, Cohen RA: Two mechanisms mediate relaxation by bradykinin of pig coronary artery: NO-dependent and -independent responses. Am J Physiol Heart Circ Physiol 1991;261:H830-H835.
22. Nakashima M, Mombouli JV, Taylor AA, Vanhoutte PM: Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest 1993;92:2867-2871.
23. Collis RE, Collins PW, Gutteridge CN, Kaul A, Newland AC, Williams DM, Webb AR: The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Med 1994;20:37-41.
24. Rittoo D, Gosling P, Simms MH, Smith SRG, Vohra RK: The Effects of hydroxyethyl starch compared with gelofusine on activated endothelium and the systemic inflammatory response following aortic aneurysm repair. Eur J Vasc Endovasc Surg 2005;30:520-524.
25. Vincent JL: The pros and cons of hdyroxyethyl starch solutions. Anesth Analg 2007;104:484-486.